Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 11145 - 11152 of 12011 results
Ninth Circuit Clarifies Extraterritorial Reach of California Antitrust Laws
February 25, 2013| Alert| Viewpoint
Energy & Clean Tech Connections: Your Law Firm Link to Industry News
February 22, 2013| Article| Viewpoint
Supreme Court Unanimously Rules Unforeseeability Bars Immunity Defense for Allegedly Anticompetitive Hospital Merger
February 21, 2013| Advisory| Viewpoint
AMR Decision Highlights Bankruptcy Court Split on Enforceability of Ipso Facto Clauses
February 20, 2013| Blog| Viewpoint
Sequestration: Responding to Government Contract Delays and Changes
February 20, 2013| Alert| Viewpoint
Mintz Ranked in Top Ten by LMG Clean Technology and Renewable Energy
February 19, 2013| Blog| Viewpoint
The New HIPAA Omnibus Rule & Your Liability -- A Detailed Review
February 17, 2013| Blog| Viewpoint
New FMLA Forms Now Available
February 15, 2013| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|